India · Delayed Price · Currency is INR Ipca Laboratories Statistics
Total Valuation
NSE:IPCALAB has a market cap or net worth of INR 402.32 billion. The enterprise value is 413.03 billion.
| Market Cap | 402.32B |
| Enterprise Value | 413.03B |
Important Dates
The last earnings date was Friday, May 29, 2026.
| Earnings Date | May 29, 2026 |
| Ex-Dividend Date | Aug 7, 2026 |
Share Statistics
NSE:IPCALAB has 253.70 million shares outstanding. The number of shares has decreased by -0.00% in one year.
| Current Share Class | 253.70M |
| Shares Outstanding | 253.70M |
| Shares Change (YoY) | -0.00% |
| Shares Change (QoQ) | -6.00% |
| Owned by Insiders (%) | 7.13% |
| Owned by Institutions (%) | 47.40% |
| Float | 139.31M |
Valuation Ratios
The trailing PE ratio is 35.26 and the forward PE ratio is 28.70. NSE:IPCALAB's PEG ratio is 1.91.
| PE Ratio | 35.26 |
| Forward PE | 28.70 |
| PS Ratio | 4.17 |
| PB Ratio | 4.22 |
| P/TBV Ratio | 5.11 |
| P/FCF Ratio | 82.78 |
| P/OCF Ratio | 35.23 |
| PEG Ratio | 1.91 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.96, with an EV/FCF ratio of 84.98.
| EV / Earnings | 36.20 |
| EV / Sales | 4.28 |
| EV / EBITDA | 20.96 |
| EV / EBIT | 26.60 |
| EV / FCF | 84.98 |
Financial Position
The company has a current ratio of 2.76, with a Debt / Equity ratio of 0.08.
| Current Ratio | 2.76 |
| Quick Ratio | 1.39 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.41 |
| Debt / FCF | 1.66 |
| Interest Coverage | 20.55 |
Financial Efficiency
Return on equity (ROE) is 13.22% and return on invested capital (ROIC) is 13.10%.
| Return on Equity (ROE) | 13.22% |
| Return on Assets (ROA) | 8.08% |
| Return on Invested Capital (ROIC) | 13.10% |
| Return on Capital Employed (ROCE) | 15.51% |
| Weighted Average Cost of Capital (WACC) | 4.65% |
| Revenue Per Employee | 5.75M |
| Profits Per Employee | 680,129 |
| Employee Count | 16,778 |
| Asset Turnover | 0.80 |
| Inventory Turnover | 1.07 |
Taxes
In the past 12 months, NSE:IPCALAB has paid 3.81 billion in taxes.
| Income Tax | 3.81B |
| Effective Tax Rate | 24.36% |
Stock Price Statistics
The stock price has increased by +16.45% in the last 52 weeks. The beta is 0.06, so NSE:IPCALAB's price volatility has been lower than the market average.
| Beta (5Y) | 0.06 |
| 52-Week Price Change | +16.45% |
| 50-Day Moving Average | 1,550.22 |
| 200-Day Moving Average | 1,453.34 |
| Relative Strength Index (RSI) | 52.05 |
| Average Volume (20 Days) | 254,081 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:IPCALAB had revenue of INR 96.46 billion and earned 11.41 billion in profits. Earnings per share was 44.98.
| Revenue | 96.46B |
| Gross Profit | 68.24B |
| Operating Income | 15.60B |
| Pretax Income | 15.65B |
| Net Income | 11.41B |
| EBITDA | 19.79B |
| EBIT | 15.60B |
| Earnings Per Share (EPS) | 44.98 |
Balance Sheet
The company has 11.98 billion in cash and 8.09 billion in debt, with a net cash position of 3.89 billion or 15.34 per share.
| Cash & Cash Equivalents | 11.98B |
| Total Debt | 8.09B |
| Net Cash | 3.89B |
| Net Cash Per Share | 15.34 |
| Equity (Book Value) | 95.24B |
| Book Value Per Share | 317.89 |
| Working Capital | 40.70B |
Cash Flow
In the last 12 months, operating cash flow was 11.42 billion and capital expenditures -6.56 billion, giving a free cash flow of 4.86 billion.
| Operating Cash Flow | 11.42B |
| Capital Expenditures | -6.56B |
| Depreciation & Amortization | 4.18B |
| Net Borrowing | -6.20B |
| Free Cash Flow | 4.86B |
| FCF Per Share | 19.16 |
Margins
Gross margin is 70.74%, with operating and profit margins of 16.18% and 11.83%.
| Gross Margin | 70.74% |
| Operating Margin | 16.18% |
| Pretax Margin | 16.22% |
| Profit Margin | 11.83% |
| EBITDA Margin | 20.51% |
| EBIT Margin | 16.18% |
| FCF Margin | 5.04% |
Dividends & Yields
This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 0.39%.
| Dividend Per Share | 6.00 |
| Dividend Yield | 0.39% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 4.59% |
| Buyback Yield | 0.00% |
| Shareholder Yield | 0.39% |
| Earnings Yield | 2.84% |
| FCF Yield | 1.21% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for NSE:IPCALAB is 1,719.61, which is 8.44% higher than the current price. The consensus rating is "Buy".
| Price Target | 1,719.61 |
| Price Target Difference | 8.44% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 11.30% |
| EPS Growth Forecast (3Y) | 18.16% |
Stock Splits
The last stock split was on January 10, 2022. It was a forward split with a ratio of 2.
| Last Split Date | Jan 10, 2022 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 8 |